QQ
微信
| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Rinucumab | Rinucumab | 1569263-06-4 |
| Tilavonemab | TILAVONEMAB (替拉奈单抗 ) | 2096513-89-0 |
| Laprituximab Emtansine | Laprituximab Emtansine | 1622327-37-0 |
| Carotuximab | Carotuximab | 1268714-50-6 |
| Elezanumab | Elezanumab | 1791416-49-3 |
| Brazikumab | Brazikumab | 1610353-18-8 |
| Tomaralimab | TOMARALIMAB (托拉利单抗 ) | 1449294-76-1 |
| Selicrelumab | 塞鲁单抗 | 1622140-49-1 |
| Larcaviximab | Larcaviximab | 1792982-56-9 |
| Spartalizumab | 斯巴达珠单抗 | 1935694-88-4 |
| Ontamalimab | Ontamalimab | 2098790-40-8 |
| Cibisatamab | 赛必妥单抗 | 2101242-53-7 |
| Enapotamab | ENAPOTAMAB单抗 | 1912423-61-0 |
| Olinvacimab | Olinvacimab | 2095504-49-5 |
| Dostarlimab | Dostarlimab | 2022215-59-2 |
| Zampilimab | Zampilimab | 2098280-42-1 |
| Cobolimab | COBOLIMAB (考伯利单抗 ) | 2022215-65-0 |
| Elipovimab | ELIPOVIMAB (依帕韦单抗 ) | 2101210-43-7 |
| Garadacimab | GARADACIMAB (加达西单抗 ) | 2162134-62-3 |
| Envafolimab | ENVAFOLIMAB (恩弗利单抗 ) | 2102192-68-5 |
